Today, people with chronic myeloid leukemia (CML) are leading pretty much normal lives. They can thank a variety of medications for being alive.

Folks living with two types of blood cancer have new choices as of today. The US Food and Drug Administration has approved Iclusig ( ponatinib ) to treat chronic myeloid leukemia ( CML ) and Philadelphia chromosome-positive acute lymphoblastic leukemia ( Ph + ALL). 

Chronic myeloid leukemia ( CML ) is a tricky cancer because it can respond well to initial therapy, but then that drug sometimes stops working. The same thing can happen when different – second-line – drugs are used. The reason for this is that the disease tends to keep changing or mutating.

A new medication for chronic myelogenous leukemia ( CML ) has been approved by the US Food and Drug Administration.

Chronic myeloid leukemia ( CML ) has a number of treatment options. And those options may be expanding in the near future. A drug still being investigated shows positive results in treating newly diagnosed CML patients.